Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway

Chen,Wei; Wang,Xiaowei; Huang,Li; Liu,Bo

doi:10.3892/etm.2015.2873

Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway

Authors:
- Wei Chen
- Xiaowei Wang
- Li Huang
- Bo Liu
View Affiliations

Affiliations: Department of Gastroenterology, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei 441000, P.R China, Department of Neurology, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei 441000, P.R China
Published online on: November 17, 2015 https://doi.org/10.3892/etm.2015.2873
Pages: 73-76
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of our study was to analyze the role of toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signal pathway on Hepcidin regulation in non‑alcoholic fatty liver disease (NAFLD). A total of 60 male Sprague‑Dawley rats were randomly divided into the control, NAFLD and intervention groups. Rats in the control group were fed with standard laboratory diet, and rats in the NAFLD and intervention groups were fed with a high‑fat diet. A final volume of 2 ml of pathenolide (10 µmol/l) was administered intraperitoneally only to the rats in the intervention group. The tissue sections were stained with hematoxylin and eosin and the pathological changes in liver tissues were observed and scored. The levels of TLR4 and NF‑κB in liver tissues were quantified by western blotting. NAFLD rats appeared to have typical liver fatty degeneration and the expression of TLR4/NF‑κB proteins and Hepcidin mRNA was significantly higher than that in the control group (P<0.05). However, the pathological changes observed in the intervention group had a marked improvement with a significant reduction in the TLR4/NF-κB protein and Hepcidin mRNA expression (P<0.05). In conclusion, the abnormal activation of the TLR4/NF-κB signaling pathway may cause NAFLD through the overexpression of Hepcidin.

View Figures

View References

1	Rinella ME: Nonalcoholic fatty liver disease: a systematic review. JAMA. 313:2263–2273. 2015. View Article : Google Scholar : PubMed/NCBI
2	Targher G, Chonchol MB and Byrne CD: CKD and nonalcoholic fatty liver disease. Am J Kidney Dis. 64:638–652. 2014. View Article : Google Scholar : PubMed/NCBI
3	Granér M, Nyman K, Siren R, Pentikäinen MO, Lundbom J, Hakkarainen A, Lauerma K, Lundbom N, Nieminen MS and Taskinen MR: Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. Circ Cardiovasc Imaging. 8:e0019792015. View Article : Google Scholar : PubMed/NCBI
4	Fargion S, Porzio M and Fracanzani AL: Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. World J Gastroenterol. 20:13306–13324. 2014. View Article : Google Scholar : PubMed/NCBI
5	Wu H, Jin M, Han D, Zhou M, Mei X, Guan Y and Liu C: Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: Regulation of lipid metabolism via PANDER-AKT pathway. Biochem Biophys Res Commun. 458:862–868. 2015. View Article : Google Scholar : PubMed/NCBI
6	Paradies G, Paradies V, Ruggiero FM and Petrosillo G: Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol. 20:14205–14218. 2014. View Article : Google Scholar : PubMed/NCBI
7	Haap M, Machann J, von Friedeburg C, Schick F, Stefan N, Schwenzer NF, Fritsche A, Häring HU and Thamer C: Insulin sensitivity and liver fat: role of iron load. J Clin Endocrinol Metab. 96:E958–E961. 2011. View Article : Google Scholar : PubMed/NCBI
8	Zhao CY, Yan L, Wang YD, Wang W, Zhou JY and Zhen Z: Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis. Zhonghua Gan Zang Bing Za Zhi. 17:683–687. 2009.(In Chinese). PubMed/NCBI
9	Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M and Wallace M: Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. 47:571–579. 2007. View Article : Google Scholar : PubMed/NCBI
10	Aboul-Enein A, El-Beshlawy A, Hamdy M, Shaheen I, El-Saadany Z, Samir A and El-Samie HA: Peripheral expression of hepcidin gene in Egyptian β-thalassemia major. Gene. 564:206–209. 2015. View Article : Google Scholar : PubMed/NCBI
11	Boumaiza M, Ezzine A, Jaouen M, Sari MA and Marzouki MN: Molecular characterization of a novel hepcidin (HepcD) from Camelus dromedarius. Synthetic peptide forms exhibit antibacterial activity. J Pept Sci. 20:680–688. 2014. View Article : Google Scholar : PubMed/NCBI
12	Ganz T: Hepcidin and iron regulation, 10 years later. Blood. 117:4425–4433. 2011. View Article : Google Scholar : PubMed/NCBI
13	Mitsuyoshi H, Yasui K, Harano Y, Endo M, Tsuji K, Minami M, Itoh Y, Okanoue T and Yoshikawa T: Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol Res. 39:366–373. 2009. View Article : Google Scholar : PubMed/NCBI
14	Tsuchiya H, Ashla AA, Hoshikawa Y, Matsumi Y, Kanki K, Enjoji M, Momosaki S, Nakamuta M, Taketomi A, Maehara Y, et al: Iron state in association with retinoid metabolism in non-alcoholic fatty liver disease. Hepatol Res. 40:1227–1238. 2010. View Article : Google Scholar : PubMed/NCBI
15	Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A and Szabo G: Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology. 54:133–144. 2011. View Article : Google Scholar : PubMed/NCBI
16	Amacher DE: Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers. 19:541–552. 2014. View Article : Google Scholar : PubMed/NCBI
17	Hassan K, Bhalla V, El Regal ME and A-Kader HH: Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol. 20:12082–12101. 2014. View Article : Google Scholar : PubMed/NCBI
18	Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar : PubMed/NCBI
19	Kelley CE, Brown AJ, Diehl AM and Setji TL: Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol. 20:14172–14184. 2014. View Article : Google Scholar : PubMed/NCBI
20	Fitzpatrick E and Dhawan A: Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. World J Gastroenterol. 20:10851–10863. 2014. View Article : Google Scholar : PubMed/NCBI